Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| DeSimone Jill | Director | 3 | $0 | $0 | 2024-06-20 |
| Wills Robert James | Director | 11 | $86.3K | $8.9K | 2024-06-20 |
| THEUER CHARLES | Director | 9 | $0 | $0 | 2024-06-20 |
| MAZANET ROSEMARY | Director | 6 | $0 | $0 | 2024-06-20 |
| CARTER MICHAEL G | Director | 9 | $150.0K | $0 | 2024-06-20 |
| LARUE WILLIAM R | Director | 11 | $0 | $0 | 2024-06-20 |
| KISNER DANIEL L | Director | 10 | $23.8K | $0 | 2024-06-20 |
| HALE DAVID F | Director | 16 | $8.9K | $17.4K | 2024-06-20 |
| Krishnan Rajesh | Chief Technology Officer | 23 | $0 | $0 | 2024-02-14 |
| Yazji Salim | Chief Medical Officer | 22 | $24.2K | $0 | 2024-02-14 |
| Leavitt Chase C. | General Counsel/Secretary | 23 | $38.7K | $0 | 2024-02-14 |
| VINCENT RICHARD G | Chief Financial Officer | 40 | $37.8K | $0 | 2024-02-14 |
| BREITMEYER JAMES B | President, CEO | 64 | $86.0K | $0 | 2024-02-14 |
| Nakanishi Xin | Director | 7 | $0 | $0 | 2023-06-28 |
| Kaufmann Gunnar F. | Chief Scientific Officer | 13 | $9.8K | $0 | 2023-06-14 |
| Chen Jinzhu PhD | Director | 2 | $0 | $0 | 2022-06-16 |
| BILINSKY IGOR | Chief Business Officer | 5 | $0 | $0 | 2021-02-11 |
| Shanghai Pharmaceutical (USA) Inc. | 10% Owner | 3 | $3.75M | $0 | 2020-07-21 |
| AKER HAZEL M | Legal Counsel | 13 | $99.9K | $0 | 2020-07-21 |
| Cho Man | Director | 4 | $0 | $0 | 2020-06-11 |
| Hsu Frank J. | Chief Medical Officer | 4 | $0 | $0 | 2020-03-17 |
| Liu Yanjun | Director | 2 | $0 | $0 | 2019-09-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| MAZANET ROSEMARY | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 3,300 | — | $0 | 3,300 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| DeSimone Jill | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| Wills Robert James | Director | P Buy | 2024-04-08 | 2024-04-10 | 3,086 | $8.96 | $27.7K | 10,000 | SEC↗ |
| Wills Robert James | Director | P Buy | 2024-03-28 | 2024-04-01 | 6,914 | $8.48 | $58.6K | 6,914 | SEC↗ |
| Wills Robert James | Director | S Sale | 2024-02-23 | 2024-02-27 | 980 | $9.04 | $8.9K | 0 | SEC↗ |
| HALE DAVID F | Director | P Buy | 2024-02-23 | 2024-02-27 | 266 | $9.04 | $2.4K | 29,673 | SEC↗ |
| HALE DAVID F | Director | P Buy | 2024-02-23 | 2024-02-27 | 714 | $9.04 | $6.5K | 714 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2024-02-14 | 2024-02-15 | 14,200 | — | $0 | 14,200 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2024-02-14 | 2024-02-15 | 14,200 | — | $0 | 14,200 | SEC↗ |
| Krishnan Rajesh | CTO/CSO | A Award deriv | 2024-02-14 | 2024-02-15 | 17,700 | — | $0 | 17,700 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2024-02-14 | 2024-02-15 | 14,200 | — | $0 | 14,200 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2024-02-14 | 2024-02-15 | 6,200 | — | $0 | 6,200 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2024-02-14 | 2024-02-15 | 28,400 | — | $0 | 28,400 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | F Tax w/h | 2024-01-03 | 2024-01-05 | 50,955 | $0.50 | $25.5K | 443,034 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | F Tax w/h | 2024-01-03 | 2024-01-05 | 4,485 | $0.50 | $2.2K | 15,426 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | F Tax w/h | 2024-01-03 | 2024-01-05 | 11,838 | $0.50 | $5.9K | 84,758 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | F Tax w/h | 2024-01-03 | 2024-01-05 | 8,868 | $0.50 | $4.4K | 140,922 | SEC↗ |
| Yazji Salim | Chief Medical Officer | F Tax w/h | 2024-01-03 | 2024-01-05 | 19,742 | $0.50 | $9.9K | 128,635 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | F Tax w/h | 2024-01-03 | 2024-01-05 | 11,838 | $0.50 | $5.9K | 44,019 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 220,000 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 177,050 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 160,000 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 12,470 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 40,000 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 75,000 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 28,750 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 177,050 | — | $0 | 177,050 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 12,470 | — | $0 | 12,470 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Krishnan Rajesh | Chief Technical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 35,120 | — | $0 | 0 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 75,000 | — | $0 | 0 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 210,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 28,750 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 280,000 | — | $0 | 0 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 109,597 | — | $0 | 109,597 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 280,000 | — | $0 | 280,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 35,120 | — | $0 | 35,120 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 0 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 0 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 109,579 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 650,000 | — | $0 | 650,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 123,750 | — | $0 | 123,750 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 637,000 | — | $0 | 637,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 750,000 | — | $0 | 750,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 66,890 | — | $0 | 66,890 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 650,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 123,750 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 637,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 750,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 66,890 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 100,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 165,000 | — | $0 | 165,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 7,000 | — | $0 | 7,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 22,000 | — | $0 | 12,240 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 12,500 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 165,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 2,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 7,000 | — | $0 | 0 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 22,000 | — | $0 | 0 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 354,400 | — | $0 | 354,400 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 92,075 | — | $0 | 92,075 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 70,600 | — | $0 | 70,600 | SEC↗ |
| Yazji Salim | Chief Medical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 0 | SEC↗ |
| Yazji Salim | Chief Medical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 55,000 | — | $0 | 0 | SEC↗ |
| Yazji Salim | Chief Medical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 92,075 | — | $0 | 0 | SEC↗ |
| Yazji Salim | Chief Medical Officer | D To issuer deriv | 2023-10-02 | 2023-10-04 | 354,400 | — | $0 | 0 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2023-10-02 | 2023-10-04 | 55,519 | — | $0 | 55,519 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | D To issuer deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 0 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2023-10-02 | 2023-10-04 | 235,000 | — | $0 | 235,000 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | D To issuer deriv | 2023-10-02 | 2023-10-04 | 55,519 | — | $0 | 0 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | D To issuer deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 0 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 28,750 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | D To issuer deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 0 | SEC↗ |
| Krishnan Rajesh | Chief Technology Officer | F Tax w/h | 2023-07-03 | 2023-07-05 | 10,897 | $0.36 | $3.9K | 55,857 | SEC↗ |
| Yazji Salim | Chief Medical Officer | F Tax w/h | 2023-07-03 | 2023-07-05 | 16,299 | $0.36 | $5.9K | 148,377 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | F Tax w/h | 2023-07-03 | 2023-07-05 | 7,069 | $0.36 | $2.5K | 149,790 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | F Tax w/h | 2023-07-03 | 2023-07-05 | 10,305 | $0.36 | $3.7K | 96,596 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | F Tax w/h | 2023-07-03 | 2023-07-05 | 4,007 | $0.36 | $1.4K | 19,911 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | F Tax w/h | 2023-07-03 | 2023-07-05 | 47,992 | $0.36 | $17.3K | 493,989 | SEC↗ |
| DeSimone Jill | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 37,500 | — | $0 | 37,500 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MAZANET ROSEMARY | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Nakanishi Xin | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | P Buy | 2023-06-14 | 2023-06-14 | 3,000 | $0.36 | $1.1K | 94,726 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | P Buy | 2023-06-12 | 2023-06-14 | 25,000 | $0.35 | $8.8K | 91,726 | SEC↗ |
| Yazji Salim | Chief Medical Officer | P Buy | 2023-04-14 | 2023-04-14 | 5,000 | $0.30 | $1.5K | 164,676 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | P Buy | 2023-04-14 | 2023-04-17 | 47,750 | $0.30 | $14.3K | 194,294 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | P Buy | 2023-04-14 | 2023-04-17 | 2,250 | $0.29 | $653 | 196,544 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2023-04-13 | 2023-04-14 | 30,000 | $0.30 | $9.0K | 156,859 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | P Buy | 2023-04-13 | 2023-04-14 | 10,000 | $0.29 | $2.9K | 106,901 | SEC↗ |
| Yazji Salim | Chief Medical Officer | P Buy | 2023-04-13 | 2023-04-14 | 10,000 | $0.29 | $2.9K | 159,676 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | P Buy | 2023-04-13 | 2023-04-17 | 100,000 | $0.29 | $29.0K | 146,544 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | P Buy | 2023-04-12 | 2023-04-14 | 15,000 | $0.29 | $4.3K | 96,901 | SEC↗ |
| Yazji Salim | Chief Medical Officer | P Buy | 2023-04-12 | 2023-04-14 | 10,000 | $0.29 | $2.9K | 149,676 | SEC↗ |
| Krishnan Rajesh | Chief Technology Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 220,000 | — | $0 | 220,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2023-02-21 | 2023-02-23 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 210,000 | — | $0 | 210,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-02-21 | 2023-02-24 | 650,000 | — | $0 | 650,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-02-21 | 2023-02-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2023-02-21 | 2023-02-24 | 42,196 | — | $0 | 42,196 | SEC↗ |
| DeSimone Jill | Director | A Award deriv | 2023-01-04 | 2023-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | F Tax w/h | 2023-01-03 | 2023-01-05 | 4,428 | $1.02 | $4.5K | 126,859 | SEC↗ |
| Yazji Salim | Chief Medical Officer | F Tax w/h | 2023-01-03 | 2023-01-05 | 9,961 | $1.02 | $10.2K | 139,676 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | F Tax w/h | 2023-01-03 | 2023-01-05 | 6,266 | $1.02 | $6.4K | 66,726 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | F Tax w/h | 2023-01-03 | 2023-01-05 | 6,091 | $1.02 | $6.2K | 81,901 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | F Tax w/h | 2023-01-03 | 2023-01-05 | 27,793 | $1.02 | $28.3K | 541,981 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | F Tax w/h | 2023-01-03 | 2023-01-05 | 1,325 | $1.02 | $1.4K | 23,918 | SEC↗ |
| Krishnan Rajesh | Chief Technology Officer | F Tax w/h | 2023-01-03 | 2023-01-05 | 6,238 | $1.02 | $6.4K | 66,754 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2022-07-28 | 2022-08-01 | 55,000 | — | $0 | 55,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2022-07-28 | 2022-08-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2022-07-28 | 2022-08-01 | 123,750 | — | $0 | 123,750 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2022-07-28 | 2022-08-01 | 28,750 | — | $0 | 28,750 | SEC↗ |
| Krishnan Rajesh | Chief Technology Officer | A Award deriv | 2022-07-28 | 2022-08-01 | 28,750 | — | $0 | 28,750 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2022-07-28 | 2022-08-01 | 28,750 | — | $0 | 28,750 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2022-07-28 | 2022-08-01 | 28,750 | — | $0 | 28,750 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award | 2022-07-28 | 2022-08-01 | 82,500 | — | $0 | 149,637 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award | 2022-07-28 | 2022-08-01 | 185,625 | — | $0 | 569,774 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award | 2022-07-28 | 2022-08-01 | 18,750 | — | $0 | 25,243 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award | 2022-07-28 | 2022-08-01 | 43,125 | — | $0 | 131,287 | SEC↗ |
| Krishnan Rajesh | Chief Technology Officer | A Award | 2022-07-28 | 2022-08-01 | 43,125 | — | $0 | 72,992 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award | 2022-07-28 | 2022-08-01 | 43,125 | — | $0 | 72,992 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award | 2022-07-28 | 2022-08-01 | 43,125 | — | $0 | 87,992 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Nakanishi Xin | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Chen Jinzhu PhD | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MAZANET ROSEMARY | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2022-06-16 | 2022-06-17 | 37,500 | — | $0 | 37,500 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-03-28 | 2022-03-28 | 2,500 | $1.40 | $3.5K | 88,162 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-03-25 | 2022-03-28 | 356 | $1.45 | $516 | 83,521 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-03-25 | 2022-03-28 | 5 | $1.48 | $7 | 83,526 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-03-25 | 2022-03-28 | 2,136 | $1.49 | $3.2K | 85,662 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-03-24 | 2022-03-28 | 3 | $1.45 | $4 | 83,165 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | P Buy | 2022-01-28 | 2022-01-31 | 5,000 | $1.63 | $8.1K | 44,867 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-01-28 | 2022-01-31 | 2,500 | $1.65 | $4.1K | 83,162 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | P Buy | 2022-01-27 | 2022-01-31 | 25,000 | $1.68 | $42.0K | 46,544 | SEC↗ |
| Yazji Salim | Chief Medical Officer | P Buy | 2022-01-27 | 2022-01-31 | 10,000 | $1.69 | $16.9K | 67,137 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | P Buy | 2022-01-27 | 2022-01-31 | 8,500 | $1.78 | $15.1K | 39,867 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-01-27 | 2022-01-31 | 5,000 | $1.80 | $9.0K | 75,662 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | P Buy | 2022-01-27 | 2022-01-31 | 5,000 | $1.70 | $8.5K | 80,662 | SEC↗ |
| Krishnan Rajesh | Chief Technology Officer | A Award deriv | 2022-01-20 | 2022-01-24 | 177,050 | — | $0 | 177,050 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2022-01-20 | 2022-01-24 | 162,457 | — | $0 | 162,457 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award deriv | 2022-01-20 | 2022-01-24 | 55,519 | — | $0 | 55,519 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2022-01-20 | 2022-01-24 | 109,579 | — | $0 | 109,579 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award deriv | 2022-01-20 | 2022-01-24 | 92,075 | — | $0 | 92,075 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2022-01-20 | 2022-01-24 | 165,000 | — | $0 | 165,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2022-01-20 | 2022-01-24 | 637,000 | — | $0 | 637,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award | 2022-01-03 | 2022-01-05 | 29,867 | — | $0 | 70,662 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award | 2022-01-03 | 2022-01-05 | 29,867 | — | $0 | 29,867 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | A Award | 2022-01-03 | 2022-01-05 | 29,867 | — | $0 | 31,367 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award | 2022-01-03 | 2022-01-05 | 6,793 | — | $0 | 6,793 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award | 2022-01-03 | 2022-01-05 | 128,557 | — | $0 | 384,149 | SEC↗ |
| Yazji Salim | Chief Medical Officer | A Award | 2022-01-03 | 2022-01-05 | 57,137 | — | $0 | 57,137 | SEC↗ |
| Krishnan Rajesh | Chief Technology Officer | A Award | 2022-01-03 | 2022-01-05 | 29,867 | — | $0 | 29,867 | SEC↗ |
| HALE DAVID F | Director | S Sale | 2021-06-30 | 2021-07-02 | 3,669 | $4.75 | $17.4K | 713,152 | SEC↗ |
| Leavitt Chase C. | General Counsel/Secretary | P Buy | 2021-06-11 | 2021-06-15 | 1,500 | $5.45 | $8.2K | 1,500 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Nakanishi Xin | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Chen Jinzhu PhD | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MAZANET ROSEMARY | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2021-03-18 | 2021-03-22 | 63,295 | — | $0 | 105,492 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2021-02-21 | 2021-02-23 | 2,000 | — | $0 | 2,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2021-02-11 | 2021-02-16 | 280,000 | — | $0 | 280,000 | SEC↗ |
| BILINSKY IGOR | Chief Business Officer | A Award deriv | 2021-02-11 | 2021-02-16 | 130,000 | — | $0 | 130,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2021-02-11 | 2021-02-16 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2021-02-11 | 2021-02-16 | 253,000 | — | $0 | 253,000 | SEC↗ |
| MAZANET ROSEMARY | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MAZANET ROSEMARY | Director | A Award deriv | 2021-01-27 | 2021-01-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2021-01-27 | 2021-02-23 | 7,000 | — | $0 | 7,000 | SEC↗ |
| CARTER MICHAEL G | Director | P Buy | 2020-09-01 | 2020-09-02 | 71,429 | $2.10 | $150.0K | 71,947 | SEC↗ |
| Shanghai Pharmaceutical (USA) | 10% Owner | P Buy deriv | 2020-07-21 | 2020-07-23 | 524,658 | $2.38 | $1.25M | 524,658 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2020-07-21 | 2020-07-23 | 20,986 | $2.38 | $49.9K | 20,986 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2020-07-21 | 2020-07-23 | 5,000 | $2.38 | $11.9K | 5,000 | SEC↗ |
| Shanghai Pharmaceutical (USA) | 10% Owner | P Buy | 2020-07-21 | 2020-07-23 | 1,049,317 | $2.38 | $2.50M | 3,544,431 | SEC↗ |
| AKER HAZEL M | Legal Counsel | P Buy | 2020-07-21 | 2020-07-23 | 41,972 | $2.38 | $99.9K | 46,987 | SEC↗ |
| KISNER DANIEL L | Director | P Buy | 2020-07-21 | 2020-07-23 | 10,000 | $2.38 | $23.8K | 10,000 | SEC↗ |
| Cho Man | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 30,000 | SEC↗ |
| Nakanishi Xin | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Cho Man | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 22,500 | — | $0 | 22,500 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Nakanishi Xin | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HALE DAVID F | Director | P Buy deriv | 2020-05-21 | 2020-05-22 | 8,706 | — | $0 | 8,706 | SEC↗ |
| HALE DAVID F | Director | P Buy | 2020-05-21 | 2020-05-22 | 17,412 | — | $0 | 716,818 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2020-03-17 | 2020-07-31 | 11,080 | — | $0 | 11,080 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2020-03-17 | 2020-07-31 | 11,080 | — | $0 | 11,080 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2020-03-17 | 2020-07-31 | 11,080 | — | $0 | 11,080 | SEC↗ |
| BILINSKY IGOR | Chief Business Officer | A Award deriv | 2020-03-17 | 2020-07-31 | 12,690 | — | $0 | 12,690 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2020-03-17 | 2020-07-31 | 66,890 | — | $0 | 66,890 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | A Award deriv | 2020-03-17 | 2020-07-31 | 16,280 | — | $0 | 16,280 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2020-03-17 | 2020-07-31 | 35,120 | — | $0 | 35,120 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2020-03-17 | 2020-07-31 | 14,260 | — | $0 | 14,260 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2020-03-17 | 2020-03-18 | 11,080 | — | $0 | 11,080 | SEC↗ |
| BILINSKY IGOR | Chief Business Officer | A Award deriv | 2020-03-17 | 2020-03-18 | 12,690 | — | $0 | 12,690 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | A Award deriv | 2020-03-17 | 2020-03-18 | 16,280 | — | $0 | 16,280 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2020-03-17 | 2020-03-18 | 14,260 | — | $0 | 14,260 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2020-03-17 | 2020-03-18 | 35,120 | — | $0 | 35,120 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2020-03-17 | 2020-03-18 | 66,890 | — | $0 | 66,890 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2020-01-07 | 2020-07-31 | 22,000 | — | $0 | 22,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2020-01-07 | 2020-01-09 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Cho Man | Director | A Award deriv | 2019-12-18 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Cho Man | Director | A Award deriv | 2019-12-18 | 2019-12-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2019-09-12 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2019-09-12 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2019-09-12 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Liu Yanjun | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2019-09-12 | 2020-07-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2019-09-12 | 2020-07-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Nakanishi Xin | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKER HAZEL M | Legal Counsel | A Award deriv | 2019-09-12 | 2019-09-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BREITMEYER JAMES B | Chief Executive Officer | A Award deriv | 2019-09-12 | 2019-09-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2019-09-12 | 2019-09-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CARTER MICHAEL G | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Liu Yanjun | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Nakanishi Xin | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| THEUER CHARLES | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BILINSKY IGOR | Chief Business Officer | A Award deriv | 2019-09-09 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BILINSKY IGOR | Chief Business Officer | A Award deriv | 2019-09-09 | 2019-09-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2019-09-05 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Kaufmann Gunnar F. | Chief Scientific Officer | A Award deriv | 2019-09-05 | 2019-09-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | A Award deriv | 2019-08-26 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | A Award deriv | 2019-08-26 | 2019-08-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BREITMEYER JAMES B | President, CEO | A Award deriv | 2019-06-18 | 2019-06-20 | 42,196 | — | $0 | 42,196 | SEC↗ |
| AKER HAZEL M | General Counsel | A Award deriv | 2019-06-07 | 2019-06-11 | 140 | — | $0 | 140 | SEC↗ |
| BREITMEYER JAMES B | President, CEO | A Award deriv | 2019-06-07 | 2019-06-11 | 733 | — | $0 | 733 | SEC↗ |
| BREITMEYER JAMES B | President, CEO | A Award deriv | 2019-06-07 | 2019-06-11 | 117,417 | — | $0 | 117,417 | SEC↗ |
| BREITMEYER JAMES B | President, CEO | A Award deriv | 2019-06-07 | 2019-06-11 | 1,467 | — | $0 | 1,467 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2019-06-07 | 2019-06-11 | 281 | — | $0 | 281 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award deriv | 2019-06-07 | 2019-06-11 | 73,385 | — | $0 | 73,385 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 281 | — | $0 | 281 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2019-06-07 | 2019-06-11 | 3,292 | — | $0 | 3,292 | SEC↗ |
| AKER HAZEL M | General Counsel | A Award | 2019-06-07 | 2019-06-11 | 4,284 | — | $0 | 4,284 | SEC↗ |
| AKER HAZEL M | General Counsel | A Award | 2019-06-07 | 2019-06-11 | 5,015 | — | $0 | 5,015 | SEC↗ |
| BREITMEYER JAMES B | President, CEO | A Award | 2019-06-07 | 2019-06-11 | 21,544 | — | $0 | 21,544 | SEC↗ |
| BREITMEYER JAMES B | President, CEO | A Award | 2019-06-07 | 2019-06-11 | 255,591 | — | $0 | 255,591 | SEC↗ |
| BREITMEYER JAMES B | President, CEO | A Award | 2019-06-07 | 2019-06-11 | 733 | — | $0 | 733 | SEC↗ |
| THEUER CHARLES | Director | A Award | 2019-06-07 | 2019-06-11 | 14,677 | — | $0 | 14,677 | SEC↗ |
| Shanghai Pharmaceutical (USA) | 10% Owner | A Award | 2019-06-07 | 2019-06-11 | 2,495,114 | — | $0 | 2,495,114 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award | 2019-06-07 | 2019-06-11 | 4,526 | — | $0 | 4,526 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award | 2019-06-07 | 2019-06-11 | 42,628 | — | $0 | 40,794 | SEC↗ |
| VINCENT RICHARD G | Chief Financial Officer | A Award | 2019-06-07 | 2019-06-11 | 1,834 | — | $0 | 1,834 | SEC↗ |
| LARUE WILLIAM R | Director | A Award | 2019-06-07 | 2019-06-11 | 10,030 | — | $0 | 10,030 | SEC↗ |
| LARUE WILLIAM R | Director | A Award | 2019-06-07 | 2019-06-11 | 16,144 | — | $0 | 16,144 | SEC↗ |
| HALE DAVID F | Director | A Award | 2019-06-07 | 2019-06-11 | 18,346 | — | $0 | 18,346 | SEC↗ |
| HALE DAVID F | Director | A Award | 2019-06-07 | 2019-06-11 | 699,406 | — | $0 | 699,406 | SEC↗ |